Amgen Q1 Profit and Revenue Beat Expectations (AMGN)

Biotechnology specialist Amgen Inc. (AMGN) late Tuesday said its first quarter earnings rose 5% from last year, beating Wall Street estimates.

The Thousand Oaks, CA-based company reported first quarter net income of $1.18 billion, or $1.48 per share, compared with $1.13 billion, or $1.20 per share, in the year-ago period. Excluding special items, adjusted profit was $1.61 per share.

Revenue rose 9% from last year to $4.05 billion.

On average, Wall Street analysts expected a smaller profit of $1.46 per share, on lower revenue of $3.93 billion.

Looking ahead, the company backed its previously-announced full-year earnings outlook of $5.90 to $6.15 per share, while analysts are looking for $6.05 per share for the year.

Amgen shares close up around 0.5% in Tuesday trading.

The Bottom Line
Shares of Amgen (AMGN) have a 2.10% dividend yield, based on today’s closing stock price of $68.63. The stock has technical support in the $61-$65 price area. If the shares can firm up, we see overhead resistance around the $70-$76 price levels.

Amgen Inc. (AMGN) is not recommended at this time, holding a DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here